Highlights Ibnsina Pharma

Equities

ISPH

EGS512O1C012

End-of-day quote Egyptian Exchange Other stock markets 03:30:00 06/06/2024 am IST			5-day change	1st Jan Change
2.6 ^EGP	-1.89%		-0.76%	-17.20%

19/05	Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03/03	Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2024	19/05	CI
Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023	03/03	CI
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Ibnsina Pharma Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	13/23/13	CI
Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2023	23/23/23	CI
Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2022	01/23/01	CI
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15	CI
Ibnsina Pharma Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	14/22/14	CI
Ibnsina Pharma Reports Earnings Results for the First Quarter Ended March 31, 2022	22/22/22	CI
Ibn Sina Pharma Company (S.A.E) acquired El Shorouk Hospital for EGP 430 million.	22/22/22	CI
Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2021	24/22/24	CI
Ibnsina Pharma Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	14/21/14	CI
Ibn Sina Pharma Company (S.A.E.) Announces Consolidated Earnings Results for the Six Months Ended June 30, 2021	16/21/16	CI
Ibnsina Pharma Reports Consolidated and Standalone Earnings Results for the First Quarter of 2021	01/21/01	CI
Ibnsina Pharma Reports Earnings Results for the Full Year 2020	04/21/04	CI
Ibn Sina Pharma (S.A.E) Announces Audited Standalone Earnings Results for the Full Year Ended December 31, 2020	01/21/01	CI
Ibn Sina Pharma (S.A.E) completed the acquisition of 75% stake in 3elagi Tech.	13/20/13	CI
Ibn Sina Pharma (S.A.E) signed an agreement to acquire 75% stake in 3elagi Tech.	09/20/09	CI
Ibnsina Pharma Reports Earnings Results for the First Quarter of 2020	09/20/09	CI
Ibnsina Pharma Announces Earnings Results for the Three Months Ended March 31, 2019	12/19/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Ibnsina Pharma

Equities

ISPH

EGS512O1C012

Highlights

Filters